Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers. (2022)
Attributed to:
Identifying a Wnt pathway inhibitor for stem cell maintenance in IBD
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41698-022-00298-0
PubMed Identifier: 35853939
Publication URI: http://europepmc.org/abstract/MED/35853939
Type: Journal Article/Review
Volume: 6
Parent Publication: NPJ precision oncology
Issue: 1
ISSN: 2397-768X